News

Partner companies' news

SAB Biotherapeutics Appoints Mark J. Ratain, MD, to the Company’s Board of Scientific Advisors
SIOUX FALLS, S.D., April 05, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics [1] ( Nasdaq: SABS [2] ), (SAB), a clinical-stage biopharmaceutical compan...
Acorn Management Partners, Administrator
— April 2022 — 460 views SABS

SAB Biotherapeutics Provides Company Update and Reports Full Year 2021 Financial Results
SIOUX FALLS, S.D., March 29, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics [1] ( Nasdaq: SABS [2] ), (SAB), a clinical-stage biopharmaceutical compa...
Acorn Management Partners, Administrator
— April 2022 — 418 views SABS

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives